Michael Bruce
Algemeen Directeur bij Exo Therapeutics, Inc.
Actieve functies van Michael Bruce
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Algemeen Directeur | 01-02-2020 | - |
Loopbaan van Michael Bruce
Eerdere bekende functies van Michael Bruce
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01-10-2017 | 01-02-2020 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01-01-2015 | 01-01-2017 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01-01-2003 | 01-01-2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2003 | 01-01-2015 |
Opleiding van Michael Bruce
| Williams College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Michael Bruce
- Ervaring
